Super User

Super User

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur

Market Intelligence & Consulting Services

Medico Marketing Team

img1
img2

Meet The Team Variation

Different events delivered by Medical Department

 

 

Medical Representative Training

Medical training Director

  • Regular training sessions
  • New Products
  • Review sessions
  • Paper reviews
  • Cycle meetings
  • Role Plays
  • Exams and Evaluations of the MRs

 

Event Management

Event leadership

  • Promotional materials
  • Iran Medical Council (IRIMC)
  • Ministry of Health (MOH)
  • Manufacturer Country
  • Medical Research (Helsinki Declaration and Code of Ethics)

 

KOL relation

Scientific communication

  • Round tables
  • Advisory Boards
  • Expert meetings
  • Etc.

 

Clinical Operations

Primary and special research

  • Clinical trial collaboration
  • Clinical data management
  • Pharmacovigilance

 

img1
img2
img3
img4

Supply Chain & Distribution

 

Pharmaceutical
Our ability to develop successful distribution solutions stems from the highly optimized pharmaceuticals distribution channels we’ve built over the last 9 years

An unparalleled range and depth of experience

Serving pharmaceutical companies’ distribution needs has always been an integral part of ExirHealth’s business. Over the years, we have been offering customers an unparalleled infrastructure, state-of-the-art facilities, vast network and dedicated customer service. Our ability to develop successful distribution solutions stems from the highly optimized pharmaceuticals distribution channels we’ve built over the last 9 years.

With our extensive geographic coverage, we are committed to reaching both urban and rural areas in every corner of the provinces in which we operate in. We have a full understanding of the market; the ability to detect trends and changes early on and, as a result can respond almost instantaneously to shifting needs. In addition to building and maintaining strong relationships with all relevant channels (hospitals, clinics, pharmacies, etc.), we continuously reinvest in our distribution and logistics network because we understand how vital these are to our customers doing business across Iran .

Consumer Health

For our consumer health/OTC clients, we focus on delivering value-added solutions that maximize point-of-purchase availability, improve in-store visibility, and optimize consumer purchases.

Tailored solutions for highly diverse markets

Throughout complex, rapidly growing markets, Exir Health is dedicated to long-term client growth. Today’s consumer health/OTC health companies face unique challenges in the diverse and expansive iran markets. The consumer health/OTC market is highly valued with major sectors typically growing at twice the global rate. Market dynamics are complex, with highly diverse geographies in different provinces , variable levels of economic development, growing urbanization and varying degrees of modern trade retail development. This diversity in the Iran market is what drives Exir Health to provide unique client solutions in each market.

Leveraging our extensive experience in the region, Exir Health has developed individualized market strategies to provide our stakeholders with highly efficient distribution solutions designed to optimize reach and customer service. These solutions cover traditional pharma channels as well as the broad range of trade channels that are critical to our clients’ success in the consumer health-related product categories. In addition we provide trade marketing solutions to maximize point-of-purchase availability, improve brand visibility and generate consumer sales. Our clients can access various Exir Health information systems to acquire category performance information to better manage their brand portfolio. All Exir Health clients enjoy the full support of a fully integrated company with a best in class quality assurance, compliance and regulatory infrastructure.

With close ties throughout Iran , Exir Health serves a wide range of clients by offering tailored solutions for an array of products and services. We look forward to further expanding our services in iran and continue to develop business ties to ensure we provide the best possible service for all out clients.

Sales & Marketing

Rethinking sales to identify, promote and prove real value

 

Product Launch

Support your global expansion with a strong local infrastructure

  • Boost sales in new therapeutic areas with highly experienced specialty sales teams.
  • Rapidly expand into one or several new geographic areas.
  • Maintain continuity of territory coverage with a zero vacancy sales team.
  • Deploy a sales force supplemented with remote engagement.


Product Launch

Support your global expansion with a strong local infrastructure

  • Boost sales in new therapeutic areas with highly experienced specialty sales teams.
  • Rapidly expand into one or several new geographic areas.
  • Maintain continuity of territory coverage with a zero vacancy sales team.
  • Deploy a sales force supplemented with remote engagement.


Product Launch

Support your global expansion with a strong local infrastructure

  • Boost sales in new therapeutic areas with highly experienced specialty sales teams.
  • Rapidly expand into one or several new geographic areas.
  • Maintain continuity of territory coverage with a zero vacancy sales team.
  • Deploy a sales force supplemented with remote engagement.


Product Launch

Support your global expansion with a strong local infrastructure

  • Boost sales in new therapeutic areas with highly experienced specialty sales teams.
  • Rapidly expand into one or several new geographic areas.
  • Maintain continuity of territory coverage with a zero vacancy sales team.
  • Deploy a sales force supplemented with remote engagement.

 

Sales and Marketing Services 

Product Strategy

  • Product portfolio optimization
  • New product development
  • Innovation capability development
  • Process and organizational delivery support

Pricing

  • Industry pricing dynamics
  • Pricing framework and optimization
  • Yield management

 

Marketing Strategy

  • Market development strategy
  • Customer insights
  • Customer and product profitability analysis
  • Marketing optimization

Brand Strategy

  • Brand management
  • Brand portfolio optimization

 

 

 Customer Relationship Management

  • Customer loyalty design & delivery
  • Value-based customer segmentation
  • CRM program design

Sales & Channel Management

  • Channel strategy development
  • Sales channel configuration and operations design
  • Resource prioritization
  • Performance measurement and reward
  • Capability development
  • Program implementation

Product Launch
A proven tactic to accomplishing commercial success
Preserve your brand with Local knowledge
Determining the best approach to launch can be challenging in Iran market. Out licensing may provide immediate commercial muscle at the expense of autonomy, but building the commercial infrastructure to independently support a successful launch may drain capital needed elsewhere. You need a partner with a deep understanding of diverse stakeholders in Iran market, new health systems and pharma branding, and the resources to implement smart strategies.

The right resources at every step
ExirHealth has supported more than 35 product launches in Iran since 2009. Guided by MNC priorities, we help MNC drive successful commercialization with a complete lineup of services. From upfront strategic planning to tactical execution, we can accurately assess the gaps in your capabilities, then rapidly fill them with highly skilled marketers, medics, regulatory experts and sales leaders.

Benefits of a commercialization partnership with ESS include:

  • Retaining full strategic control over your product.
  • Keeping internal resources focused on your core portfolio.
  • Maximizing the value of your product to your company.
  • Retaining the flexibility for future business opportunities.
  • Reduced operational risk.

Finding partners in an evolving marketplace
Maintaining status quo within sales operations isn’t an option if you want to stay ahead of your competitors. Sales models must be attuned to market trends, and teams must be flexible and responsive to a dynamic marketplace. All the necessary resources may not be in-house, but in order to realize maximum efficiencies perhaps they shouldn’t be.

Tailoring teams to your goals
With 8 years of experience, 35 brand launches, more than 50 specialty and primary care sales representatives in 20 Provinces, and customer satisfaction scores that consistently exceed 90%, ExirHealth knows how to build winning teams. In addition to recruiting, training and managing your sales force, our pharmaceutical sales solutions go far beyond those of traditional sales organizations, including:
•    Boost sales in new therapeutic areas with highly experienced specialty sales teams.
•    Rapidly expand into one or several  geographic areas.
•    Maintain continuity of territory coverage with a zero vacancy sales team.
•    Deploy a sales force supplemented with remote engagement.

Integrated Channel Management
A connected engagement strategy to reach physicians the right way
Getting your product message in front of physicians has become more interesting. Restrictions in the number of sales rep visits to healthcare providers (HCPs), Higher number of patients to see, and an increased amount of information through a variety of digital channels, it is getting harder every day for your message to reach HCPs effectively. Relying only on traditional face-to-face interaction through sales representatives won’t show the returns that could be achieved through a multichannel approach

Connect results to improve your probability of success
Choosing the right channel mix and understanding the impact of your activities requires you to:

  • Understand  your Iranian target audiences preferred communication channels
  • Connect the various channels to track results and make more informed decisions 
  • Employ a good balance between non-personal, personal, live communication
  • Be flexible - adjust the channel mix, according to context
  • Ensure consistency of message through different channels while keeping content fresh

An integrated multichannel engagement solution with ExirHealth allows you to:

  • Tap into our deep understanding of healthcare systems and stakeholders
  • Use our ability to reach stakeholders and identify the channels that resonate best with them
  • Leverage our capabilities in designing, executing and measuring your multi-channel program
  • Rely on us to provide a solution that is compliant with regulations – across Iran MarketWe can help you design and execute a tailored strategy at any point in your product’s lifecycle – starting in the planning stages before brand launch all the way past loss of exclusivity. For established brands, applying an integrated multichannel engagement strategy can help you generate greater value and support you during heartland strategy implementation.

Regulatory & Market Access

The power of possibilities

  comprehensive expertise can help you confidently interact with regulatory affairs authorities for different therapeutic area and package and present all the information necessary to allow regulatory authorities to make the right decision.
100% of approximately 150 submissions to the FDO have passed technical validation for registering IRC.
50+ DIAF and 1.5 million pages published (all document types, e.g., DIAF /pharmacoeconomic/CTD ).
70% of our regulatory professionals hold advanced degrees, with an average of more than 16 years of experience.


Regulatory Affair
The power of possibilities
EXIRHEALTH ’ comprehensive expertise can help you confidently interact with regulatory affairs authorities for different therapeutic area and package and present all the information necessary to allow regulatory authorities to make the right decision for passing registration prices

  • 100% of approximately 35 submissions to the FDO have passed technical validation for registering IRC.
  • 50+ DIAF and 30000 pages published (all document types, e.g., DIAF /pharmacoeconomic/CTD ).
  • 70% of our regulatory professionals hold advanced degrees, with an average of more than 16 years of experience.


Anticipate what Iran payers want
Payers are pushing for more evidence of value, bringing a new level of scrutiny to formulary and reimbursement decisions. Working together at the earliest stages of your commercial planning, ESS can help you tailor your value proposition and pricing to local and national health plans. Our team of national account managers works with the majority of commercial plans that influence most of the prescriptions written in the Iran. As Iran ministry of health regulatory requirements keep evolving, we’re here to help you increase your chances of regulatory approval.

The power of possibilities
Put our relationships to work for your product. We’ve worked with a majority of all payers – including top managed care organizations, national welfare minister. To learn more, contact our regulatory team.

ExirHealth regulatory team includes over 6 professionals, to help you navigate regulatory requirements throughout your product’s development lifecycle. Comprehensive expertise and capacity to help you gain regulatory approval. On the road to regulatory approval, you invest years and millions of dollars in drug development. Don’t let the complexities of filing across multiple countries delay your launch. With ExirHealth integrated cross-functional expertise we can help increase the probability of successfully registering your products.
The proof of our success ? 87% of ExirHealth Product registration submission to MOH has passed technical validation and registered in IDL in past 5 years.
•    Having sufficient knowledge of drug registration rules & regulations for registration of products
•    Adequately capability of registering new products in the Drug National List
•    Closed relation with MOH to the established and proven commitment & credibility
•    Well knowledge of the drug; raw material and food supplement approval process and registration bureaucracy
•    Submitting registration documents to MOH with a great speed without any delay subsequently pursuing the case, in MOH continuously to receive the needed licenses.

Merck finally bags FDA approval for Bridion

The US FDA has approved Merck & Co's Bridion to reverse the effects of neuromuscular blockade induced by muscle relaxants used during surgery.

ArchiMed acquires life sciences consultancy Deallus

ArchiMed, Europe's first independent private equity healthcare specialist, has acquired majority control of Deallus Consulting.